Abbott Is Bouncing Back From Baby Formula Problems And Lost Covid Test Sales Abbott Laboratories is rebounding from last year’s manufacturing shutdown of its U.S. baby formula plant thanks to strong medical device sales taking the place of lost revenue of COVID-19 tests.